Newton, MA-based Beacon Endoscopic, a medical device startup, said yesterday it has closed $5 million in Series B financing from MVM Life Science Partners, based in London and Boston. The company also said it has received new capital from existing angel investors. Beacon has developed a fine needle aspiration system for endoscopic ultrasound and endoscopic bronchial ultrasound; the system has FDA clearance for endoscopic ultrasound use and is expected to be available in the fourth quarter of this year. Beacon Endoscopic started in late 2008 and is led by CEO Peter Rogal and co-founders Brian Tinkham and Christopher Thompson.
Author: Gregory T. Huang
Greg is a veteran journalist who has covered a wide range of science, technology, and business. As former editor in chief, he overaw daily news, features, and events across Xconomy's national network. Before joining Xconomy, he was a features editor at New Scientist magazine, where he edited and wrote articles on physics, technology, and neuroscience. Previously he was senior writer at Technology Review, where he reported on emerging technologies, R&D, and advances in computing, robotics, and applied physics. His writing has also appeared in Wired, Nature, and The Atlantic Monthly’s website. He was named a New York Times professional fellow in 2003.
Greg is the co-author of Guanxi (Simon & Schuster, 2006), about Microsoft in China and the global competition for talent and technology. Before becoming a journalist, he did research at MIT’s Artificial Intelligence Lab. He has published 20 papers in scientific journals and conferences and spoken on innovation at Adobe, Amazon, eBay, Google, HP, Microsoft, Yahoo, and other organizations. He has a Master’s and Ph.D. in electrical engineering and computer science from MIT, and a B.S. in electrical engineering from the University of Illinois, Urbana-Champaign.
View all posts by Gregory T. Huang